Effect of irinotecan on HMGB1, MMP9 expression, cell cycle, and cell growth in breast cancer (MCF-7) cells

Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum

(2016) Masashi Takano et al.   Asia-Pacific Journal of Clinical Oncology

Irinotecan-induced dysarthria: A case report and review of the literature

(2016) Krista G Ramirez et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients: A Meta-analysis

(2013) Jian Song et al.   Asian Pacific Journal of Cancer Prevention

HMGB1 in Cancer: Good, Bad, or Both?

(2013) R. Kang et al.   CLINICAL CANCER RESEARCH

Regulation of nucleosome dynamics by histone modifications

(2013) Gabriel E Zentner et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

(2012) Joshua P. Sasine et al.   Anti-Cancer Agents in Medicinal Chemistry

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

(2012) Helena Erlandsson Harris et al.   Nature Reviews Rheumatology

Irinotecan induces senescence and apoptosis in colonic cells in vitro

(2012) Emil Rudolf et al.   TOXICOLOGY LETTERS

High-mobility group box 1 and cancer

(2010) Daolin Tang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

HMG modifications and nuclear function

(2010) Qingchun Zhang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

(2010) L Liu et al.   LEUKEMIA

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry

(2010) Maxim Isabelle et al.   Proteome Science

The translocation of HMGB1 during cell activation and cell death

(2009) Julie Gauley et al.   AUTOIMMUNITY

Nuclear functions of the HMG proteins

(2009) Raymond Reeves   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms